Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels

Canadian Journal of Anesthesia

Volumn 58, Issue 2, 2011, Pages 191-205

  Forman, Stuart A ^a   Miller, Keith W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; ALCOHOL DERIVATIVE; ALFAXALONE; ANESTHETIC AGENT; AZIETOMIDATE; BARBITURIC ACID DERIVATIVE; ETOMIDATE; HALOTHANE; ION CHANNEL; NICOTINIC RECEPTOR; PROPOFOL; UNCLASSIFIED DRUG;

ALLOSTERISM; DRUG BINDING SITE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SELECTIVITY; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW;

ALLOSTERIC REGULATION; ANESTHETICS, GENERAL; ANIMALS; BINDING SITES; CYSTEINE LOOP LIGAND-GATED ION CHANNEL RECEPTORS; ETOMIDATE; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, GABA-A; RECEPTORS, NICOTINIC;

EID: 79951722762     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-010-9419-9     Document Type: Review

References (74)

1. Jurd R, Arras M, Lambert S, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J 2003; 17: 250-2.
2. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348: 2110-24. (Pubitemid 36583307)
3. Hemmings HC Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005; 26: 503-10. (Pubitemid 41338560)
4. Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 2004; 5: 709-20. (Pubitemid 39150142)
5. Grasshoff C, Drexler B, Rudolph U, Antkowiak B. Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des 2006; 12: 3665-79. (Pubitemid 44509632)
6. Zeller A, Jurd R, Lambert S, et al. Inhibitory ligand-gated ion channels as substrates for general anesthetic actions. Handb Exp Pharmacol 2008; 31-51.
7. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 2008; 9: 370-86. (Pubitemid 351556044)
8. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965; 12: 88-118.
9. Perutz MF. Mechanisms of cooperativity and allosteric regulation in proteins. Q Rev Biophys 1989; 22: 139-237.
10. Cui Q, Karplus M. Allostery and cooperativity revisited. Protein Sci 2008; 17: 1295-307.
11. Changeux JP, Taly A. Nicotinic receptors, allosteric proteins and medicine. Trends Mol Med 2008; 14: 93-102.
12. Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 2009; 8: 733-50.
13. Changeux JP, Edelstein SJ. Allosteric mechanisms of signal transduction. Science 2005; 308: 1424-8. (Pubitemid 40791288)
14. Dodson BA, Braswell LM, Miller KW. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes. Mol Pharmacol 1987; 32: 119-26. (Pubitemid 17112323)
15. Rusch D, Zhong H, Forman SA. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA-A receptors accounts for both direct activation and agonist modulation. J Biol Chem 2004; 279: 20982-92. (Pubitemid 38656498)
16. Arias HR, Kem WR, Trudell JR, Blanton MP. Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor. Int Rev Neurobiol 2003; 54: 1-50. (Pubitemid 44943686)
17. Baenziger JE, Corringer PJ. 3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels. Neuropharmacology 2010; DOI: 10.1016/j.neuropharm.2010.08.007.
18. Olsen RW, Chang CS, Li G, Hanchar HJ, Wallner M. Fishing for allosteric sites on GABA(A) receptors. Biochem Pharmacol 2004; 68: 1675-84. (Pubitemid 39286472)
19. Miller KW. The nature of sites of general anaesthetic action. Br J Anaesth 2002; 89: 17-31. (Pubitemid 34778100)
20. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. J Mol Biol 2005; 346: 967-89. (Pubitemid 40215523)
21. Bocquet N, Nury H, Baaden M, et al. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 2009; 457: 111-4.
22. Hilf RJ, Dutzler R. Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel. Nature 2009; 457: 115-8.
23. Weng Y, Yang L, Corringer PJ, Sonner JM. Anesthetic sensitivity of the Gloeobacter violaceus proton-gated ion channel. Anesth Analg 2010; 110: 59-63.
24. Nury H, Van Renterghem C, Weng Y, et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 2010; in press.
25. A receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J Neurosci 2006; 26: 11599-605.
26. Campagna-Slater V, Weaver DF. Molecular modelling of the GABAA ion channel protein. J Mol Graph Model 2007; 25: 721-30. (Pubitemid 46177685)
27. Ernst M, Bruckner S, Boresch S, Sieghart W. Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 2005; 68: 1291-300. (Pubitemid 41539985)
28. Jansen M, Akabas MH. State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments. J Neurosci 2006; 26: 4492-9. (Pubitemid 44315348)
29. Bali M, Jansen M, Akabas MH. GABA-induced intersubunit conformational movement in the GABAA receptor alpha 1M1-beta 2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site. J Neurosci 2009; 29: 3083-92.
30. Dostalova Z, Liu A, Zhou X, et al. High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracy-cline- inducible stable mammalian cell line: GABA(A) and serotonin receptors. Protein Sci 2010; 19: 1728-38.
31. Bosterling B, Trevor A, Trudell JR. Binding of halothane-free radicals to fatty acids following UV irradiation. Anesthesiology 1982; 56: 380-4. (Pubitemid 12104235)
32. el-Maghrabi EA, Eckenhoff RG, Shuman H. Saturable binding of halothane to rat brain synaptosomes. Proc Natl Acad Sci USA 1992; 89: 4329-32.
33. Husain SS, Forman SA, Kloczewiak MA, et al. Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anesthetic. J Med Chem 1999; 42: 3300-7. (Pubitemid 29409718)
34. Husain SS, Ziebell MR, Ruesch D, et al. 2-(3-Methyl-3H-diaziren- 3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels. J Med Chem 2003; 46: 1257-65. (Pubitemid 36428231)
35. Eckenhoff RG, Xi J, Shimaoka M, Bhattacharji A, Covarrubias M, Dailey WP. Azi-isoflurane, a photolabel analog of the commonly used inhaled general anesthetic isoflurane. ACS Chem Neurosci 2010; 1: 139-45.
36. Pratt MB, Husain SS, Miller KW, Cohen JB. Identification of sites of incorporation in the nicotinic acetylcholine receptor of a photoactivatible general anesthetic. J Biol Chem 2000; 275: 29441-51. (Pubitemid 32043819)
37. Chiara DC, Dangott LJ, Eckenhoff RG, Cohen JB. Identification of nicotinic acetylcholine receptor amino acids photolabeled by the volatile anesthetic halothane. Biochemistry 2003; 42: 13457-67. (Pubitemid 37444895)
38. Ziebell MR, Nirthanan S, Husain SS, Miller KW, Cohen JB. Identification of binding sites in the nicotinic acetylcholine receptor for [3H]azietomidate, a photoactivatable general anesthetic. J Biol Chem 2004; 279: 17640-9. (Pubitemid 38560529)
39. Firestone LL, Sauter JF, Braswell LM, Miller KW. Actions of general anesthetics on acetylcholine receptor-rich membranes from Torpedo californica. Anesthesiology 1986; 64: 694-702. (Pubitemid 16118083)
40. Chiara DC, Hong FH, Arevalo E, et al. Time-resolved photolabeling of the nicotinic acetylcholine receptor by [3H]azietomidate, an open-state inhibitor. Mol Pharmacol 2009; 75: 1084-95.
41. Nirthanan S, Garcia G 3rd, Chiara DC, Husain SS, Cohen JB. Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector. J Biol Chem 2008; 283: 22051-62.
42. Liao M, Sonner JM, Husain SS, et al. R (+) etomidate and the photoactivable R (+) azietomidate have comparable anesthetic activity in wild-type mice and comparably decreased activity in mice with a N265M point mutation in the gamma-aminobutyric acid receptor beta3 subunit. Anesth Analg 2005; 101: 131-5. (Pubitemid 40853363)
43. Bali M, Akabas MH. Defining the propofol binding site location on the GABAA receptor. Mol Pharmacol 2004; 65: 68-76. (Pubitemid 38113887)
44. Krasowski MD, Koltchine W, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998; 53: 530-8. (Pubitemid 28162877)
45. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-9. (Pubitemid 27415220)
46. Grutter T, Changeux JP. Nicotinic receptors in wonderland. Trends Biochem Sci 2001; 26: 459-63. (Pubitemid 32735440)
47. Li GD, Chiara DC, Cohen JB, Olsen RW. Numerous classes of general anesthetics inhibit etomidate binding to gamma-amino-butyric acid type A (GABAA) receptors. J Biol Chem 2010; 285: 8615-20.
48. Roth SH, Forman SA, Braswell LM, Miller KW. Actions of pentobarbital enantiomers on nicotinic cholinergic receptors. Mol Pharmacol 1989; 36: 874-80. (Pubitemid 20019559)
49. Miller KW, Addona GH, Kloczewiak MA. Approaches to proving there are general anesthetic sites on ligand gated ion channels. Toxicol Lett 1998; 100-101: 139-47. (Pubitemid 29069141)
50. Forman SA, Miller KW. High acetylcholine concentrations cause rapid inactivation before fast desensitization in nicotinic acetyl-choline receptors from Torpedo. Biophys J 1988; 54: 149-58.
51. Maconochie DJ, Steinbach JH. The channel opening rate of adult- and fetal-type mouse muscle nicotinic receptors activated by acetylcholine. J Physiol 1998; 506: 53-72. (Pubitemid 28046037)
52. Yamodo IH, Chiara DC, Cohen JB, Miller KW. Conformational changes in the nicotinic acetylcholine receptor during gating and desensitization. Biochemistry 2010; 49: 156-65.
53. Arevalo E, Chiara DC, Forman SA, Cohen JB, Miller KW. Gating-enhanced accessibility of hydrophobic sites within the transmembrane region of the nicotinic acetylcholine receptor's {delta}-subunit. A time-resolved photolabeling study. J Biol Chem 2005; 280: 13631-40. (Pubitemid 40517257)
54. Auerbach A, Akk G. Desensitization of mouse nicotinic acetyl-choline receptor channels. A two-gate mechanism. J Gen Physiol 1998; 112: 181-97. (Pubitemid 28369159)
55. Andreeva IE, Pedersen SE. Conformational asymmetry of nicotinic acetylcholine receptor (AChR) desensitization. Biophys J 2005; 89: 3052-Pos.
56. Cash DJ, Subbarao K. Different effects of pentobarbital on two gamma-aminobutyrate receptors from rat brain: channel opening, desensitization, and an additional conformational change. Biochemistry 1988; 27: 4580-90.
57. Chang Y, Weiss DS. Allosteric activation mechanism of the alpha1beta2gamma2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine. Biophys J 1999; 77: 2542-51. (Pubitemid 29519500)
58. O'Shea SM, Wong LC, Harrison NL. Propofol increases agonist efficacy at the GABA(A) receptor. Brain Res 2000; 852: 344-8. (Pubitemid 30035171)
59. Steinbach JH, Akk G. Modulation of GABA(A) receptor channel gating by pentobarbital. J Physiol 2001; 537: 715-33. (Pubitemid 34026603)
60. A receptor in general anaesthesia. Neuropharmacology 2003; 45: 57-71.
61. Tomlin SL, Jenkins A, Lieb WR, Franks NP. Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals. Anesthesiology 1998; 88: 708-17. (Pubitemid 28120205)
62. Yang J, Uchida I. Mechanisms of etomidate potentiation of GABAA receptor-gated currents in cultured postnatal hippocampal neurons. Neuroscience 1996; 73: 69-78.
63. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ. The interaction of the general anesthetic etomidate with the gamma- aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci USA 1997; 94: 11031-6.
64. Hill-Venning C, Belelli D, Peters JA, Lambert JJ. Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor. Br J Pharmacol 1997; 120: 749-56.
65. Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 2006; 444: 486-9. (Pubitemid 44809065)
66. Desai R, Ruesch D, Forman SA. Gamma-amino butyric acid type A receptor mutations at b2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity. Anesthesiology 2009; 111: 774-84.
67. Stewart D, Desai R, Cheng Q, Liu A, Forman SA. Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation Mol Pharmacol 2008; 74: 1687-95
68. McKernan RM, Rosahl TW, Reynolds DS, et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000; 3: 587-92. (Pubitemid 30332078)
69. Williams DB, Akabas MH. Gamma-aminobutyric acid increases the water accessibility of M3 Membrane-spanning segment residues in gamma-aminobutyric acid type A receptors. Biophys J 1999; 77: 2563-74. (Pubitemid 29519502)
70. Mercado J, Czajkowski C. Gamma-aminobutyric acid (GABA) and pentobarbital induce different conformational rearrangements in the GABA A receptor alpha1 and beta2 pre-M1 regions. J Biol Chem 2008; 283: 15250-7.
71. Rusch D, Forman SA. Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors. Anesthesiology 2005; 102: 783-92. (Pubitemid 40462858)
72. Akk G, Steinbach JH. Activation and block of recombinant GABA(A) receptors by pentobarbitone: a single-channel study. Br J Pharmacol 2000; 130: 249-58. (Pubitemid 30261034)
73. Rosen A, Bali M, Horenstein J, Akabas MH. Channel opening by anesthetics and GABA induces similar changes in the GABAA receptor M2 segment. Biophys J 2007; 92: 3130-9. (Pubitemid 46684574)
74. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-12.